Leadership

Dr Keswani is an accomplished physician-scientist with executive leadership experience in both large pharma and small biotech. He is a former Neurology faculty member at The Johns Hopkins Hospital and an elected Fellow of the Royal College of Physicians, United Kingdom. Sanjay was Senior Vice President of R&D at Hoffman La Roche, a...
Read more >>

Dr Keswani is an accomplished physician-scientist with executive leadership experience in both large pharma and small biotech. He is a former Neurology faculty member at The Johns Hopkins Hospital and an elected Fellow of the Royal College of Physicians, United Kingdom. Sanjay was Senior Vice President of R&D at Hoffman La Roche, and Vice President of Exploratory and Clinical Translational Research at Bristol-Myers Squibb, where he was responsible for multiple therapeutic areas including Immunology, Neuroscience, Rare Diseases, Fibrosis and Virology. He has held CEO and CMO positions in biotech with experience of successful Nasdaq IPO (Annexon), acquisition (MiroBio by Gliead), venture fundraising (Series A, B, D rounds), and multiple industry partnerships. Sanjay has been instrumental in the development of several approved medicines, including Risdiplam, Emgality, Faricimab, Cymbalta, Aimovig and Deucravacitnib. Sanjay completed his residency in Neurology and fellowships in Neuroimmunology and Neurophysiology at Johns Hopkins. He graduated in medicine at St. Bartholomew’s Hospital (UK’s oldest hospital founded in 1123) and holds a First Class honors BSc degree from St. Mary’s Hospital, London in Pathology & Basic Medical Sciences (Immunology).

A world-renowned expert in Neuroimmunology who pioneered the field of nervous system repair, protection, and maintenance by the immune system. Schwartz is a professor of Neuroimmunology at the Weizmann Institute of Science (WIS). She was the first to suggest, against the prevailing dogma at the time, that circulating immune cells are e...
Read more >>

A world-renowned expert in Neuroimmunology who pioneered the field of nervous system repair, protection, and maintenance by the immune system. Schwartz is a professor of Neuroimmunology at the Weizmann Institute of Science (WIS). She was the first to suggest, against the prevailing dogma at the time, that circulating immune cells are essential for supporting life-long functional brain plasticity in health and disease, and should be harnessed to help fighting brain pathologies. These results led to the paradigm-shifting approach of developing an immunotherapy to combat neurodegenerative diseases. Her scientific publications have been extremely influential, as reflected by their high citation scores. Schwartz has received numerous national and international awards, and served as president of the International Society of Neuroimmunology (2016-2018).

Prior to joining ImmunoBrain in 2015, Roee worked for Babcock Power, Inc. in its nuclear power generation unit as a business controller and started his career as an investment banker with Merrill Lynch. Roee holds a bachelor’s degree in Economics from Columbia University (magna cum laude) and an MBA from the Wharton School of the Unive...
Read more >>

Prior to joining ImmunoBrain in 2015, Roee worked for Babcock Power, Inc. in its nuclear power generation unit as a business controller and started his career as an investment banker with Merrill Lynch. Roee holds a bachelor’s degree in Economics from Columbia University (magna cum laude) and an MBA from the Wharton School of the University of Pennsylvania.

Tommaso is a Neurologist with extensive experience in neuroimmunology, focusing on the role of immune cells in neurological disorders such as Multiple Sclerosis and Alzheimer’s Disease. His expertise is backed by over 10 years in preclinical model research, shaping a deeper understanding of these diseases. After completing his residenc...
Read more >>

Tommaso is a Neurologist with extensive experience in neuroimmunology, focusing on the role of immune cells in neurological disorders such as Multiple Sclerosis and Alzheimer’s Disease. His expertise is backed by over 10 years in preclinical model research, shaping a deeper understanding of these diseases. After completing his residency in neurology at San Raffaele Hospital in Milan, Tommaso pursued his PhD at the Weizmann Institute of Science, further enriching his clinical and research capabilities. During his PhD, he authored numerous scientific papers, underscoring the interaction between the brain and the immune system.

Over 20 years of experience in global biopharmaceutical companies, running operations and R&D teams, leading CMC and CMO activities from early phase development through commercial production.  Sharona served as Senior Director, Head of Bio-Analytical Development, CMC Biosimilars for Teva Pharmaceuticals. Prior to that Sharona was D...
Read more >>

Over 20 years of experience in global biopharmaceutical companies, running operations and R&D teams, leading CMC and CMO activities from early phase development through commercial production.  Sharona served as Senior Director, Head of Bio-Analytical Development, CMC Biosimilars for Teva Pharmaceuticals. Prior to that Sharona was Director of Analytical Development and CMC project manager in BTG, Ferring. Sharona holds an M.SC. from Ben-Gurion University, Ph.D from PARIS VI University and Pasteur Institute in protein engineering, structure and function and MBA in management and business psychology from The college of management.

Neuroimmunologist with over 15 years of biomedical experience in developing therapeutic approaches to neurodegenerative conditions. Kuti joined ImmunoBrain when the company was founded, following licensing of the technology that was developed at the Weizmann Institute of Science in his Ph.D. and Postdoctoral studies at Prof. Schwartz’s...
Read more >>

Neuroimmunologist with over 15 years of biomedical experience in developing therapeutic approaches to neurodegenerative conditions. Kuti joined ImmunoBrain when the company was founded, following licensing of the technology that was developed at the Weizmann Institute of Science in his Ph.D. and Postdoctoral studies at Prof. Schwartz’s laboratory. Kuti holds a M.Sc. in Medical Science from Tel-Aviv University, and a Ph.D. in Neurobiology from the Weizmann Institute of Science.

An experienced clinical Project Manager with more than 22 years of demonstrated management of global clinical studies (phase I-IV) across the US, EU and Israel, having worked across large global pharmaceuticals, CRO and emerging biotech companies.

An experienced clinical Project Manager with more than 22 years of demonstrated management of global clinical studies (phase I-IV) across the US, EU and Israel, having worked across large global pharmaceuticals, CRO and emerging biotech companies.

An experienced regulatory and quality affairs manager, with over 20 years of hands-on experience in clinical development of innovative medicinal products across a number of therapeutic areas. In-depth understanding of regulatory requirements for drugs and biologics from early phase development through to phase 3 clinical trials worldwi...
Read more >>

An experienced regulatory and quality affairs manager, with over 20 years of hands-on experience in clinical development of innovative medicinal products across a number of therapeutic areas. In-depth understanding of regulatory requirements for drugs and biologics from early phase development through to phase 3 clinical trials worldwide.